Find Clinical Trials
Effects of S 18886 on platelet function in type 2 diabetic patients treated by low-dose aspirin and with elevated levels of thromboxane A2. A multicentre, randomised, double-blind, cross-over study comparing S 18886 30 mg o.d. versus aspirin 100 mg o.d. administered orally.
Servier Protocol Code:
CL2-18886-031
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2008-005262-31
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Diabetes - Type II
- S018886
- TERUTROBAN
Other study id numbers
Other identification numbers the study may be known by.
- CL2-18886-031